Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 9.16 M9.58 M8.93 M8.98 M9 M 36.49 M Research & development ————— — Operating income -535 K395 K-1.78 M-35 K645 K -777 K Non-Operating Income, Total 104 K362 K470 K394 K145 K 1.37 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 109 K77 K166 K41 K67 K 351 K Unusual income/expense -5 000285 K304 K353 K78 K 1.02 M Pretax income -431 K757 K-1.31 M359 K790 K 594 K Equity in earnings ————— — Taxes -38 K114 K-72 K116 K46 K 204 K Non-controlling/minority interest ————— — After tax other income/expense -12 K-11 K-12 K-14 K-10 K -47 K Net income before discontinued operations -393 K643 K-1.24 M243 K744 K 390 K Discontinued operations ————— — Net income -393 K643 K-1.24 M243 K744 K 390 K Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -393 K643 K-1.24 M243 K744 K 390 K Basic earnings per share (Basic EPS) -0.020.03-0.070.020.04 0.02 Diluted earnings per share (Diluted EPS) -0.020.03-0.070.020.04 0.02 Average basic shares outstanding 18.61 M18.59 M18.38 M18.46 M18.63 M — Diluted shares outstanding 18.61 M18.6 M18.38 M18.46 M18.66 M — EBITDA -582 K603 K-1.67 M427 K940 K 299 K EBIT -854 K354 K-1.96 M128 K645 K -831 K Cost of revenue 20.53 M22.75 M19.09 M19.97 M21.61 M 83.41 M Other cost of goods sold ————— — Depreciation & amortization (cash flow) 272 K249 K287 K299 K295 K 1.13 M